![]() | Only 14 pages are availabe for public view |
Abstract he concept of acute renal failure (ARF) has undergone significant reexamination in recent years. However, not only has there been a lack of consensus regarding the concept of ARF, but also there has been, until very recently, no consensus on the diagnostic criteria or clinical definition of ARF. Distressingly, this has resulted in multiple different definitions being used. The Acute Dialysis Quality Initiative (ADQI) proposed the RIFLE criteria to define and stage acute kidney dysfunction. The acronym RIFLE stands for the three severity stages of risk, injury, and failure (in order of increasing severity) and the two outcome stages of loss and end-stage kidney disease. The three severity stages are defined on the basis of either increases in serum creatinine or decreases in urine output, where the more severe of either criterion is used. The two outcome criteria, loss and end-stage kidney disease, are defined by the duration of loss ofkidney function.Renal transplantation is the best form of renal replacement therapy for patients with end stage renal disease (ESRD), in comparison to dialysis, as it is associated with higher patient survivals, lower hospitalization rate and a superior quality of life. Renal failure persisting after transplantation is called delayed graft function (DGF).The major causes of DGF, which has a major impact on graft survival are: ATN, hyperacute rejection, acute rejection, urinary tract obstruction and atheroemboli or thrombosis of the renal artery or vein. Causes of acute renal failure in early posttransplantation include: acute rejection, ATN, cyclosporine or tacrolimus nephrotoxicity, urinary tract obstruction, decreased renal perfusion, infection and recurrence of primary disease. The aim of this study is to evaluate the prognostic value of RIFLE criteria in acute renal failure in early post renal transplant patients. We applied the RIFLE criteria in renal transplant recipients (RTRs) who developed acute kidney injury early post-transplantation. Summary 215 This study is, to our knowledge, the first study to apply RIFLE criteria in renal transplant recipients despite they are exposed to many risk factors, more vulnerable to develop AKI and managed, in some centers, in special ICU. Sixty-eight renal transplant recipients (RTRs), in the National Institute of Urology and Nephrology (NIUN) in Cairo, were included in this study. These 68 RTRs were classified into two groups (A and B). Group A (57 subjects) were retrospectively studied while group B (11 subjects) were prospectively studied. In our study, we found that the frequency of acute kidney injury 64.9% in retrospective cohort (class R 26.3%, class I 22.8% and class F 15.8%) and 45.5% in prospective cohort. We found that RIFLE criteria as a whole had a sensitivity for graft loss of 87.5%, specificity of 38.8%, positive predictive value (PPV) of 18.9%, negative predictive value(NPV) of 95% and accuracy of 45.6%. Class F only had sensitivity for graft loss of 80.0%, specificity of 79.2% PPV of 44.4%, NPV of 95% and accuracy of 79.3%.In prospective cohort, we found that RIFLE criteria had a sensitivity for graft loss of 100.0%, specificity of 60.0%, PPV of 20.0%, NPV of 100.0% and accuracy of 63.6%. In all subjects with AKI in retrospective cohort, we found that RIFLE criteria as a whole had a sensitivity for graft rejection of 77.8% , specificity of 37.5,PPV of 18.9%,NPV of 90% and accuracy of 43.8%. Class F only had a sensitivity of for graft rejection 66.7%, specificity of 78.3%, PPV of 44.4 %, NPV of 90% and accuracy of 75.8%. In prospective cohort, we found that RIFLE criteria had a sensitivity for graft rejection of 50.0%, specificity of 55.6%, PPV of 20.0 %, NPV of 83.3%, accuracy of 54.5%. In all subjects with AKI in retrospective cohort, we found RIFLE criteria as a whole had a sensitivity for residual kidney injury, at day 90 post-transplantation,of 100.0%, specificity of 43.5%, PPV of 29.7%, NPV of 100.0%, accuracy of 54.3%. Class F only had a sensitivity for residual kidney injury, at day 90 post-transplantation of 100.0%,In prospective cohort, we found that RIFLE criteria had a sensitivity for CAD of 100%, specificity of 75.0%, PPV of 60.0%, NPV of 100.0%, accuracy of 81.8%. In the retrospective cohort, we found that odds ratio was 4.4 for cases for graft loss, 2.1 for cases for development of graft rejection and 2.5 for cases for development of CAD but the difference was notstatistically significant while odds ratio was 8 for cases for development of RKI and the difference was statistically highly significant. In class F only in retrospective cohort, we found that odds ratio was 15.2 for cases for graft loss and the difference was statistically highly significant while odds ratio was 7.2 for cases for development of graft rejection, 9.5 for cases for development of RKI and 6 for cases for development of CAD and the difference was statistically significant. |